Correlation Between Teva Pharma and Enliven Therapeutics

Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Teva Pharma Industries and Enliven Therapeutics, you can compare the effects of market volatilities on Teva Pharma and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Enliven Therapeutics.

Diversification Opportunities for Teva Pharma and Enliven Therapeutics

-0.29

Correlation Coefficient

Teva Pharma  Enliven Therapeutics

Very good diversification

The 3 months correlation between Teva and Enliven is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Teva Pharma i.e., Teva Pharma and Enliven Therapeutics go up and down completely randomly.

Pair Corralation between Teva Pharma and Enliven Therapeutics

Given the investment horizon of 90 days Teva Pharma Industries is expected to under-perform the Enliven Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Teva Pharma Industries is 2.07 times less risky than Enliven Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Enliven Therapeutics is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  2,307  in Enliven Therapeutics on July 13, 2024 and sell it today you would earn a total of  390.00  from holding Enliven Therapeutics or generate 16.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Teva Pharma Industries  vs.  Enliven Therapeutics

Teva Pharma Industries

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharma Industries are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Teva Pharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Enliven Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in November 2024.

Pair Trading with Teva Pharma and Enliven Therapeutics

The main advantage of trading using opposite Teva Pharma and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.

The idea behind Teva Pharma Industries and Enliven Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.